WE@HealthTech
Michal Fisher is an accomplished professional in corporate development and business strategy, currently serving as Vice President of Corporate Development at LifeSci Partners since June 2020. Fisher holds advisory board membership at WE@HealthTech and previously owned Annadex Ltd., a consulting firm focused on the pharmaceuticals and medical devices sector. Experience includes roles in business development and licensing at Neopharm Group and SK Pharma, where Fisher managed strategic alliances and directed corporate development at TrioxBio. Additional entrepreneurial experience includes founding Argaman Design Products. Education includes a Master's degree in Law for Business Graduates and a Bachelor's degree in Biotechnology, both from Bar-Ilan University.
This person is not in any offices
WE@HealthTech
Women comprise about 70% of the HealthTech industry work force. Out of the 30 companies listed in the Biomed Index there are only two women CEOs amongst a total of sixty CEOs and Chairmen. The share value of companies that include women on their boards are higher by an average of 44% (Goldman Sachs). FORTUNE 500 companies with a larger number of women in senior management positions have better financial results (Catalyst). It follows that proper representation of women in top managerial levels will serve not only social and gender equality goals, but also organizational, business, and economic goals and performance. In partnership with 8400 we introduce a HealthTech launchpad program to promote junior women managers to executive positions throughout the ecosystem.